KCT0003527招募中未知
The magnetic resonance imaging assessment of non-alcoholic fatty liver disease and the evaluation of prognostic factors in patients undergoing bariatric surgery
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 59(Year)（—）
- 性别
- All
入选标准
- •Subjects who understood this clinical study and provided written informed consent to join the study by his or her own decision
- •- Aged 19 or more years or less than 60 years
- •- Subjects who have body mass index =30 kg per square meter and metabolic disease (at least one the following: impaired fasting glucose, hemoglobin A1c 5.7% or more, diabetes, nonalcoholic fatty liver disease, hypertension, hypertriglyceridemia, or metabolic syndrome).
- •- Absence of specific congenital diseases or absence of other chronic diseases and their symptom or signs requiring specific treatment, except for metabolic diseases
排除标准
- •- Aged less than 19 years or 60 years or more
- •- Pregnant or lactating women
- •- Body weight >159 kg
- •- Drug abusers
- •- Alcohol consumption (alcohol intake >20 g/day for women; >30 g/day for men) during = 3months in the past 5 years
- •- Psychiatric patients on medical care or medication or subjects with bulimia
- •- Those with AST or ALT level higher than 5 times the upper limit of normal
- •- Those with platelet count < 60,000 per microliter or with prothrombin time longer than 4 seconds or more than the upper limit of normal (14 seconds)
- •- Contraindications to MRI examination
- •- Other specific liver diseases except for NAFLD
- •- Liver cirrhosis with ascites or biliary tract diseases
- •- Medications causing fatty liver (e.g., corticosteroids, tamoxifen, amiodarone, methotrexate
- •and others) within a year
- •- Other systemic diseases seemed to be inappropriate for study participation
- •- Subjects with HIV infection
- •- Subjects with ischemic heart diseases
- •- Subjects with estimated glomerular filtration rates < 45 ml/min/1.73 square meters
- •- Subjects with clinical or subclinical hyperthyroidism or hypothyroidism
- •- Inappropriate for study participation at the discretion of attending physicians
研究者
相似试验
进行中（未招募）
1 期
Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron OverloadMedDRA version: 19.0Level: LLTClassification code 10028534Term: Myelodysplastic syndrome NOSSystem Organ Class: 100000004864EUCTR2016-000246-62-Outside-EU/EEAovartis53
尚未招募
不适用
Evaluating the use of Magnetic Resonance Imaging and Contrast Enhanced Mammography after MagTrace® usemammacarcinoma10006291breast cancerNL-OMON51366Zuyderland Medisch Centrum40
招募中
不适用
ltrasound and magnetic resonance imaging to assess muscle contractile performance in FSHD.disease of Landouzy-Dejerinefacioscapulohumeral dystrophy1002839610028302NL-OMON56047Radboud Universitair Medisch Centrum100
尚未招募
不适用
Magnetic Resonance Imaging (MRI) and radiological study of Rheumatoid Arthritis treated with Adalimumab and non-biological agents to assess the impact of disease control on MRI manifestations and joint structure preservation.Musculoskeletal - Other muscular and skeletal disordersRheumatoid ArthritisACTRN12612000903886Emeritus Research180
进行中（未招募）
不适用
A Phase 2a Magnetic Resonance Imaging Study of the Safety and Efficacy of MLN1202 in patients with Multiple Sclerosis - Not appilcableThe purpose of this study is to investigate the safety, PK parameters, PD responses, and clinical responses of multiple dose administration of MLN1202 in patients with relapsing remitting multiple sclerosis (RRMS).EUCTR2004-002567-24-CZMillennium Pharmaceuticals, Inc.160